Cardiac Biotech Solutions Inc. (CBSC)
OTCMKTS · Delayed Price · Currency is USD
0.0375
-0.0005 (-1.32%)
Aug 14, 2025, 1:00 PM EDT
Cardiac Biotech Solutions Market Cap
Cardiac Biotech Solutions has a market cap or net worth of $6.15 million as of August 15, 2025. Its market cap has decreased by -52.25% in one year.
Market Cap
6.15M
Enterprise Value
n/a
Revenue
50.37K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since April 28, 2016, Cardiac Biotech Solutions's market cap has decreased from 74.24M to 6.15M, a decrease of -91.71%. That is a compound annual growth rate of -23.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 6.23M | -40.58% |
| Dec 31, 2024 | 10.49M | -32.63% |
| Dec 29, 2023 | 15.57M | -33.04% |
| Dec 30, 2022 | 23.25M | -65.04% |
| Dec 31, 2021 | 66.51M | -39.18% |
| Dec 31, 2020 | 109.35M | 3,632.66% |
| Dec 3, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2016 | Upgrade Pro | Upgrade Pro |
| Apr 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 597.56M |
| Elite Pharmaceuticals | 567.50M |
| Nika Pharmaceuticals | 360.27M |
| Northwest Biotherapeutics | 349.08M |
| American Oncology Network | 337.45M |
| CytoDyn | 325.38M |